Vaxcyte, Inc. (PCVX) Misses Q2 EPS by 5c

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q2 EPS of ($1.22), $0.05 worse than the analyst estimate of ($1.17).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• Goldman Sachs (GS) Reiterated at Market Perform by Citizens on Constructive Backdrop
• Evercore ISI Upgrades Canadian National Railway (CNI) to Outperform
• JuNeng Technology files for IPO on Nasdaq at $4-$5 per share